MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants
Ryan Allway May 9th, 2023 Psychedelics, Top Story MindBio clinical trial published in Peer Reviewed Paper Biological Psychiatry First of 8 significant publications on LSD-Microdosing from a Phase 1 clinical trial Phase 1 Clinical trial produced outstanding mood responses in healthy participants MindBio is developing a Microdosing treatment protocol... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )